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Abstract
Background: Jaagsiekte sheep retrovirus (JSRV) is a type D retrovirus capable of transforming target cells in vitro
and in vivo. The Envelope (Env) gene from JSRV and from related retroviruses can induce oncogenic transformation,
although the detailed mechanism is yet to be clearly understood. Host cell factors are envisaged to play a critical
determining role in the regulation of Env-mediated cell transformation.
Results: JSRV Env-mediated transformation of a lung adenocarcinoma cell line induced rapid proliferation,
anchorage-independent growth and tumor formation, but completely abrogated the migration ability. An analysis
of the signaling scenario in the transformed cells suggested the involvement of the ERK pathway regulated by
Sprouty2 in cell migration, and the PI3K-Akt and STAT3 pathways in proliferation and anchorage-independence. On
the other hand, in a normal lung epithelial cell line, Env-mediated transformation only decreased the migration
potential while the other functions remained unaltered. We observed that Env induced the expression of a tumor
suppressor, Sprouty2, suggesting a correlation between Env-effect and Sprouty2 expression. Overexpression of
Sprouty2 per se not only decreased the migratory potential and tumor formation potential of the target cells but
also made them resistant to subsequent Env-mediated transformation. On the other hand, over expression of the
functional mutants of Sprouty2 had no inhibitory effect, confirming the role of Sprouty2 as a tumor suppressor.
Conclusions: Our studies demonstrate that Env and Sprouty2 have a functional relationship, probably through
shared signaling network. Sprouty2 functions as a tumor suppressor regulating oncogenic transformation of cells,
and it therefore has the potential to be exploited as a therapeutic anti-cancer agent.
Background
T h eE n v e l o p ep r o t e i n so fm a n yr e t r o v i r u s e sh a v eb e e n
identified to be directly involved in oncogenic transfor-
mation of cells leading to the evolution of a new para-
digm. Friend Spleen Focus Forming Virus (SFFV) was
the first virus to be identified to be linked to oncogen-
esis induced by a retroviral Env protein [1]. Tumor for-
mation by SFFV was reported to involve the mitogen-
activated protein kinase (MAPK) and the phosphatidyli-
nositol 3-kinase (PI3K) pathways, with a number of host
factors governing the susceptibility to tumor formation
[1]. Structural proteins of Avian Hemangioma Virus
(AHV) and Mouse Mammary Tumor Virus (MMTV)
have also been shown to be involved in oncogenic trans-
formation [1]. Env genes from Jaagsiekte sheep retro-
virus (JSRV) and Enzootic Nasal Tumor Virus (ENTV)
are both known to act as oncogenes. They can trans-
form cell lines in vitro, using similar set of signaling
pathways involving the MAPK and PI3K, and when
expressed in vivo they can induce tumors in animals
[2-4]. Detailed investigation of the retroviral Env genes
could reveal the underlying mechanisms and signaling
pathways implicated in oncogenic transformation.
JSRV is an acutely transforming betaretrovirus that
induces contagious pulmonary adenocarcinoma in sheep
[5] which resembles a subtype of human adenocarci-
noma [6]. The Env oncogene of JSRV is capable of
transforming target cells in vivo as well as in vitro,
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ways [3,7-10]. The JSRV Envelope protein harbors a
putative binding site for the p85 regulatory subunit of
PI3K in its cytoplasmic tail [11], and the amino acid
Y590 present at this site is envisaged to play a crucial
role in tumorigenesis [12]; mutation of this amino acid
has been reported to reduce the transformation effi-
ciency of Envelope [13,14]. The surface domain of JSRV
Envelope protein is capable of activating an independent
signaling pathway leading to the transformation of target
cells [15]. Induction of the PI3K/Akt pathway is consid-
ered essential for Env-mediated cellular transformation
[13]. However, in some cell types, Env-mediated trans-
formation induced the MAPK pathway [8], suggesting
that both the PI3K and MAPK pathways can be modu-
lated by Env. Development of lung tumors has been
reported by lung-specific expression of Env gene in
transgenic [16] or normal mice [3], confirming its role
as an oncogene.
Cell growth control networks involve oncoprotein-
and tumor suppressor protein-regulated signaling path-
ways with increasingly diverse functions and complex
interactions for each set of proteins. While some onco-
protein-tumor suppressor pairs like Mdm2 and p53
[17], mixed lineage leukemia protein and menin [18],
MSP58 and PTEN [19] are capable of direct physical
interaction, other cryptic indirect interactions are yet to
be unraveled. This study focuses on the functional inter-
action between the Env oncogene of Jaagsiekte sheep
retrovirus (JSRV) and the tumor suppressor, human
Sprouty2.
The Sprouty family comprises of non-autonomous sig-
naling proteins that function in feedback circuits invol-
ving the Ras/MAP kinase pathway [20,21] and act as
tumor suppressors. Sprouty was first discovered in Dro-
sophila [22], and later its isoforms were identified in
many organisms. Human Sprouty2 is a 35 kDa polypep-
tide known to associate with a wide range of signaling
molecules like c-Cbl [23], human Seven in Absentia
homolog 2 (SIAH2) [24], protein phosphatase 2A
(PP2A) [25] and the adaptor protein, CrkL [26] by
means of its key tyrosine residue Y55, which is tyrosine
phosphorylated upon stimulation [27,28]. Sprouty2 can
bind to Grb2 through the SH3 binding motif in the C-
terminus [25]. It can also bind to Shp2 phosphatase
[29], Raf1 and Tesk1 via the cysteine rich domain
(CRD) [30,31]. Human Sprouty2 is known to inhibit cell
migration and proliferation in response to serum and
growth factors [32]. When overexpressed, it is capable
of inhibiting anchorage-independent cell growth, cell
migration and invasion [33], tumor growth and metasta-
sis [34]. Like most tumor suppressors, the expression of
Sprouty is downregulated in many cancers such as
breast cancer [35], prostate cancer [36,37], liver cancer
[38,39], non-small cell lung cancer [40] and B-cell lym-
phomas [41] by variable mechanisms depending on the
individual cancer type.
Our study indicates that the biochemical status of the
cell plays a crucial role in determining its susceptibility
to oncogenic transformation. We have identified a novel
relationship between the tum o rs u p p r e s s o rS p r o u t y 2
and the Env oncogene in vitro, both signaling through
overlapping pathways. Overexpression of Sprouty2
seems to inhibit the oncogenic transformation induced
by Env, resulting in suppressed tumor formation poten-
tial. We found that amino acid Y55 is crucial for Spro-
uty2 function.
Results and Discussion
Env-mediated transformation induces Sprouty2 and
inhibits cell migration
To analyze the in vitro transformation induced by JSRV
Env gene in normal as well as the cancer cell lines
derived from human lung, the full length Env gene from
JSRV was cloned in pBluescript vector under control of
the CMV promoter and used for transfection of the
lung adenocarcinoma cell line A549 and the immorta-
lized lung epithelial cell line BEAS-2B. An analysis of
the genes transiently induced by Env in A549 cells three
and six days post transfection showed upregulation
of the tumor suppressor Sprouty2 when analyzed by
semi-quantitative RT-PCR using different template con-
centrations (Figure 1A). This novel phenomenon of an
oncogene upregulating a tumor suppressor was not
observed in BEAS-2B cells transiently transfected with
the Env gene (data not shown). Regulation of the
expression of Sprouty2 in the cells occurs at multiple
levels [42], and therefore the exact reason for increased
Sprouty2 expression in A549-Env could not be ascer-
tained. We assumed that the upregulation of Sprouty2
might be a standby effect in the course of modulation of
cell signaling network by Env. We created stable cell
lines overexpressing Sprouty2 as well as stable Env-
transformed cell lines. The expression level of Sprouty2
mRNA in these cell lines was ascertained by quantitative
RT-PCR. The results revealed that A549-Spr had 2.9-
fold increased amount of Sprouty2 transcripts while
A549-Env had a 6-fold increase in Sprouty2 levels com-
pared to A549 (Figure 1B). On the other hand, BEAS-
2B-Env cell line had only 2.9-fold increase in the expres-
sion of Sprouty2 mRNA compared to BEAS-2B
(Figure 1C). These findings support our theory that
Sprouty2 induction has a positive correlation to Env-
mediated transformation.
In addition to Sprouty2, another candidate tumor sup-
pressor HYAL2, was also found to be induced by Env-
mediated transformation of A549 cells (data not shown);
the tumor suppressor activity of HYAL2 is reported to be
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Figure 1 Induction of Sprouty2 and inhibition of cell migration in JSRV Env transformed cells. (A) A549 cells were transfected with a
plasmid carrying JSRV Env gene (T) or the empty vector (C), and the expression of Sprouty2 and b-actin was monitored on days 3 and 6 post
transfection by RT-PCR using different template concentrations (500 ng and 250 ng). Data represent two independent experiments. (B) and (C)
Quantitative RT-PCR analysis depicting the fold increase in Sprouty2 mRNA levels in the stable cell lines A549-Spr and A549-Env compared to
A549 (*P < 0.0007, **P < 0.0001) (B) and in BEAS-2B-Env compared to BEAS-2B (C) *P < 0.0001. (D) Western blot analysis of the expression of
Sprouty2 protein and b-actin in stably transformed cell lines compared to the parental cell lines. Data represent five independent experiments.
(E) and (F) Cell migration assay: Equal number of A549, A549-Spr and A549-Env cells (E) or BEAS-2B and BEAS-2B-Env cells (F) were allowed to
migrate across the 8 μm porous membrane in a Boyden chamber in response to serum. After 15 h, the migrated cells were fixed, stained and
counted (*P < 0.0001). (G) The effect of 200 pmoles of Sprouty2-specific siRNA on the migration ability of A549, A549-Env, BEAS-2B and BEAS-2B-
Env cells compared to control siRNA (*P = 0.014, **P = 0.0169, ***P = 0.034, ****P = 0.0111). Corresponding changes in Sprouty2 protein levels
compared to b-actin control are depicted in the Western blot shown below the bar diagram for the respective cell lines. (C) indicates control
siRNA and (Sp) indicates Sprouty2 siRNA. Data represent two independent experiments.
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are known to suppress or inactivate tumor suppressors,
some tumor suppressors are known to be recruited for
oncogene-induced functions such as DNA damage [44],
and some proteins like SnoN are identified to function as
an oncogene as well as a tumor suppressor [45].
The functional relationship between the oncogenes
and the tumor suppressors is therefore multifaceted,
and we went ahead to study the correlation between
JSRV Env oncogene and Sprouty2 tumor suppressor. An
analysis of Sprouty2 protein levels in the stable cell lines
revealed a significant upregulation in A549-Spr and
A549-Env compared to A549, and in BEAS-2B-Env
compared to BEAS-2B (Figure 1D). We deduced that
the increased expression of Sprouty2 might have signifi-
cant physiological ramifications and went ahead to test
this hypothesis.
Overexpression of Sprouty2 is known to interfere with
cell migration and invasion [33]. So, the migration abil-
ity of the cell lines under study was compared by allow-
ing them to migrate across a porous membrane in a
Boyden chamber. A549 cells per se exhibited high
migration potential which was reduced by ~70% in
A549-Spr, while A549-Env cells were unable to migrate
(Figure 1E). Similarly, BEAS-2B cells had good migration
capability whereas BEAS-2B-Env cells exhibited ~80%
reduction in their migration potential (Figure 1F). The
effect of Env-transformation on the migration ability
was drastic in A549-Env cells abrogating their migration
potential, whereas in BEAS-2B-Env cells, the effect was
severe resulting in reduced migration ability. Therefore,
we hypothesize that Sprouty2 might have a hand in the
compromised migration potential of these cells.
To verify the role of Sprouty2 in the regulation of cell
migration, A549, A549-Env, BEAS-2B and BEAS-2B-Env
cells were treated with 200 pmoles of siRNA for Spro-
uty2 or with control siRNA and then allowed to
migrate. It was observed that siRNA-mediated inhibition
of Sprouty2 expression resulted in a corresponding
enhancement in cell motility (Figure 1G). The enhance-
ment was more prominent in A549-Env and BEAS-2B-
Env cells that had higher levels of Sprouty2 initially and
consequently very low migration potential. Inhibition of
Sprouty2 expression in the cells enhanced their migra-
tion ability, thereby confirming that Sprouty2 played an
inhibitory role in cell migration.
To investigate in detail the physiological consequences
brought about by Env and Sprouty2, further investiga-
tions were carried out.
Env induces proliferation and colony formation in A549-
Env
Proliferation and invasion are two distinct fundamental
components occupying opposing ends of a spectrum in
malignant cells and are not necessarily displayed by the
same cells. Invasion, migration and branching morpho-
genesis are exclusive characteristics of highly invasive
cells while highly proliferative cells are highly tumori-
genic and display anchorage-independent growth in soft
agar [46]. Anchorage-independent growth is an attribute
of oncogenic transformation by Env that causes cells to
loose contact inhibition resulting in the formation of
distinct foci in culture [47]. The cell lines were further
investigated for their proliferation potential and ancho-
rage-independent growth.
A549-Env had a higher proliferation rate with ~4-fold
more cells after 96 hours than A549 and A549-Spr;
increased proliferation being a characteristic feature of
oncogene-induced transformation (Figure 2A). On the
other hand, both BEAS-2B and BEAS-2B-Env had com-
parable proliferation rates (Figure 2B). Our results clearly
demonstrate that the loss of invasive ability induced by
JSRV Env is distinct from the enhanced proliferation
function. Env-mediated transformation had converted
the highly invasive A549 cells into highly proliferative
A549-Env cells. Our results suggest that the choice of
invasion versus proliferation and tumor formation func-
tions is more likely to be governed by distinct pathways
of signaling, which are probably evoked independently.
In colony formation assay, A549-Env cells formed a
number of distinct, large colonies in soft agar in 12
days, a characteristic feature of JSRV Env-mediated
transformation (Figure 2C). A549-Spr showed inhibition
of colony formation, probably due to the inhibitory
effect of Sprouty2, as reported earlier [33]. A549,
although known to be capable of anchorage-independent
growth, could form only very small colonies by day 12,
probably owing to its lower proliferation rate compared
to A549-Env. It is clear that Env had induced higher
proliferation rate and colony formation in A549-Env
cells in spite of high levels of Sprouty2. Both BEAS-2B
and BEAS-2B-Env could not form colonies in soft agar
suggesting that Env transformation had less effect in the
normal epithelial cell line BEAS-2B.
BEAS-2B cells are immortalized human lung epithelial
cells that have low transfection efficiency [48], and the
reproducibility of transformation assays is reported to be
difficult [49]. Therefore it is not surprising that Env-
mediated transformation of BEAS-2B could induce only
limited biochemical and physiological alterations. In an
attempt to unravel the underlying mechanisms responsible
for Env-mediated transformation, an analysis of the status
of signaling molecules in these cell lines was carried out.
In vivo tumorigenesis is inhibited by Sprouty2, but
enhanced by Env
To investigate the in vivo tumor forming potential, A549,
A549-Spr, A549-Env, BEAS-2B or BEAS-2B-Env cells
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to form tumors. A549 was capable of forming tumors
in vivo while the tumor forming potential was decreased
in A549-Spr that overexpresses the tumor suppressor
Sprouty2 (Figure 3A). A549-Env was capable of forming
massive tumors, characteristic of oncogenic transforma-
tion. All the tumors had pushing margins rather than
invading margins at the time of termination of the experi-
ment, and in vivo invasiveness was not detected.
T h eg r o w t hr a t eo ft u m o r sa si n d i c a t e db yt h ep r o -
gressive increase in tumor volume (Figure 3B) as well as
tumor weight (Figure 3C) was the greatest in A549-Env
(~2.3 g) and the lowest in A549-Spr (~0.1 g) compared
to A549 (~0.8 g) (Figure 3B and 3C). The inhibitory
effect of overexpressed Sprouty2 in tumor formation
that has been reported earlier [34] is confirmed by our
observations.
All the tumors were sectioned and stained with
hematoxylin and eosin and the presence of proliferat-
ing tumor cells was confirmed (Figure 3D). The sec-
tions showed a poorly differentiated adenocarcinoma
composed of cells with hyperchromatic nuclei. The
tumor formed by A549-Env showed increased cellular-
ity owing to the high proliferation rate of A549-Env
cells. BEAS-2B and BEAS-2B-Env failed to form
tumors in SCID mice, behaving more like normal
epithelial cells without much permanent alterations
in their functionality. An analysis of the signaling
scenario in these cell types gave an insight into their
biochemical attributes.
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Figure 2 JSRV Env induces proliferation and colony formation in A549-Env cells.( Aa n dB )E q u a ln u m b e r( 1×1 0
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A549-Spr and A549-Env cells (A) or BEAS-2B and BEAS-2B-Env cells (B) were allowed to proliferate for four days and live cells were counted
every 24 h. (C) A549, A549-Spr and A549-Env cells were cultured in soft agar to assess their anchorage-independent colony formation ability. The
colonies were counted and photographed on day 12.
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Figure 3 Env enhances and Sprouty2 inhibits tumor formation in SCID mice. (A) Pictures of inv i v otumors formed by A549, A549-Spr and
A549-Env cells injected into the subcutaneous tissue of SCID mice (5-7 mice per group) and excised on day 34. (B) The growth rate of tumors
formed by the respective cell lines in SCID mice is represented as increase in tumor volume monitored for up to 5 weeks. (C) Average weight of
tumors resected from SCID mice 34 days after injection (*P = 0.0003, **P = 0.0006). (D) Hematoxylin and eosin (H&E) staining of sections of
xenografts resected from SCID mice to confirm the presence of malignant cells. Magnification 400×.
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Characterization of the molecular pathways leading to
cancer is a major step towards understanding and com-
bating the disease [50]. The alterations induced by Spro-
uty2 and Env in the signaling scenario of A549 were
investigated by Western blot. The mechanism of JSRV
Env-mediated transformation of cells is not clear and is
reported to modulate the PI3K and MAPK pathways
[48]. Sprouty proteins are feedback negative regulators
of the ERK pathway [51] that is thought to regulate cell
invasion [52,53]. Upon analysis, A549 was found to have
high levels of phosphor-ERK; A549-Spr had very low
levels; and in A549-Env, phosphor-ERK was not
detected (Figure 4A). Similarly, BEAS-2B had high levels
of phosphor-ERK, which was decreased in BEAS-2B-
Env. These observations are consistent with the
increased expression of Sprouty2 in the respective
transformed cell lines compared to their parental
counterparts.
TWIST is a transcription factor that has been detected
in various carcinomas and is suggested to enhance the
invasive and metastatic ability of cancer cells [54-56].
The expression of TWIST was significantly reduced in
A549-Env and BEAS-2B-Env compared to A549 and
BEAS-2B respectively (Figure 4A). These observations
are consistent with the decreased migration potential of
A549-Env and BEAS-2B-Env.
T h ep 3 8M A P Kp a t h w a yi sr e p o r t e dt oh a v ea n t i -o r
pro- proliferative functions depending on the levels of
kinase activity and the interplay between all the signal-
ing pathways [57]. Phosphorylation of p38 MAPK was
decreased in A549-Spr compared to A549, but was sig-
nificantly enhanced in A549-Env, probably owing to
Env-induced signaling. However, in BEAS-2B, the phos-
phorylation of p38 MAPK was high, which was not seen
in BEAS-2B-Env (Figure 4A). The implication of signal-
ing mediated by p38 MAPK in BEAS-2B cells is not
clear.
The PI3K/Akt pathway is known to play a crucial role
in cell proliferation and survival and shows a high fre-
quency of alterations in cancer [58,59]. Akt phosphory-
lation was marginally increased in A549-Spr compared
to A549. But, A549-Env had very high levels of phos-
phor-Akt, showing a positive correlation with the
observed high proliferation rate (Figure 4A). Similarly,
BEAS-2B-Env showed an increase in the phosphoryla-
tion of Akt compared to BEAS-2B, consistent with the
reported involvement of PI3K/Akt pathway in Env-
induced transformation [13], although the proliferation
rate of all the BEAS-2B cell lines remained similar.
The tumor suppressor phosphatase and tensin homo-
logue (PTEN) is a negative regulator of the PI3K/Akt
pathway [60] that can suppress cell growth and tumor
formation [61,62]. Active PTEN was lower in A549-Env
cells compared to A549 and A549-Spr or to the inactive
phosphor-PTEN level (Figure 4A). In BEAS-2B and
BEAS-2B-Env, PTEN and phospho PTEN levels were
high and comparable, consistent with their inability to
form tumors.
The transcription factor STAT3 is hypothesized to
play a role in anchorage-independence [63] and cell
growth [64]. In A549-Env, high levels of phosphor-
STAT3 were detected both in the nucleus and the cyto-
plasm, indicating over activation, consistent with the
increased growth and colony forming potential of the
cells (Figure 4B). In A549 that is capable of anchorage-
independent growth, phospho STAT3 was detected in
the nucleus. But in A549-Spr, BEAS-2B and BEAS-2B-
Env, all of which are impaired in anchorage-independent
colony formation, phospho STAT3 level in the nuclear
fraction was very low (Figure 4B). Increased activation
of Akt, STAT3 and reduced expression of PTEN and
TWIST are likely to have contributed to the high prolif-
eration and colony formation potential of A549-Env.
Matrix metalloproteinases (MMPs) are enzymes that
are involved in the breakdown of the extracellular
matrix abetting invasion and metastasis of cancer cells
[65]. Tissue inhibitors of metalloproteinases (TIMPs) are
inhibitors of MMPs, which decrease cell migration [66].
Usually the MMP/TIMP ratio (MMP2/TIMP2 and
MMP9/TIMP1) determines the invasiveness of the cells
and is known to be altered in many cancers [67]. To
a d d r e s st h er o l eo fM M P sa n dT I M P si na l t e r i n gt h e
migration ability of the cell lines under study, the activ-
ity of MMPs was evaluated by gelatin zymogram and
the amount of TIMPs by Western blot. MMP levels
were high, and TIMP levels were very low in A549, an
invasive cell line (Figure 4C and 4D). In A549-Env,
MMP2 level was relatively less, and MMP9 was hardly
detectable while TIMP levels remained high, consistent
with its reduced migration potential (Figure 4C and 4D).
A549-Spr, in spite of having similar levels of MMPs and
TIMPs like A549-Env, had less activity in the cell migra-
tion assay (Figure 1E). In BEAS-2B and BEAS-2B-Env,
the levels of MMPs and TIMPs were low and compar-
able (data not shown). Elevated TIMPs and decreased
MMP9 levels seem to have contributed to the decreased
migration efficiency of A549-Spr and A549-Env. Overall,
the signaling status of the cells is consistent with the
manifested functions in the respective cell lines.
PI3K/Akt and ERK pathways regulate proliferation and cell
migration
The MAPK (p44/42) and Akt pathways have been impli-
cated in JSRV Env-mediated transformation in many cell
types [8,48]. Since the ERK and PI3K/Akt pathways
appear to be involved in cell migration and proliferation
respectively in A549 cells, in order to confirm the same,
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the respective pathways to study their effect on invasion
and proliferation.
A549 and BEAS-2B cells are intrinsically invasive and
responded differently to the inhibitors of ERK and PI3K.
The migration ability of A549 cells was reduced in the
presence of either of the MEK inhibitors, U0126 or
PD98059 while the PI3K inhibitor LY294002 had no
effect (Figure 5A). This observation confirms that the
ERK pathway is required for cell migration in A549.
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Figure 4 Alteration of signal transduction by Env and Sprouty2. (A) Cell lysates were prepared by homogenization of A549, A549-Spr, A549-
Env, BEAS-2B and BEAS-2B-Env cells. The proteins were separated on 10% acrylamide gel, transferred to nitrocellulose membrane and probed
with various antibodies. The results show the levels of phospho p38 MAPK, p38 MAPK, phospho p44/42 ERK, p44/42 ERK, phospho Ser473 Akt,
Akt, TWIST, phospho PTEN, PTEN and b-actin in the indicated cell lines. (B) Proteins were extracted from cytoplasmic (cy) and nuclear (nu)
fractions of the cells and the levels of phospho STAT3 and STAT3 were ascertained by Western blot. (C) MMP Zymogram: Conditioned media
obtained from the cell lines was assayed for gelatinase activity using 10% SDS-PAGE gel to estimate MMP activity. (D) Conditioned media
obtained from the cell lines was concentrated; the secreted proteins were separated by SDS-PAGE and immunoblotted with antibodies against
TIMP1 and TIMP2.
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A549-Spr and A549-Env might be due to the inhibition
o ft h eE R Kp a t h w a yp r o b a b l yc a u s e db yt h eu p r e g u l a -
tion of Sprouty2. Inhibition of the p44/42 MAPK path-
way by pharmacological inhibitors is known to abolish
JSRV Env-mediated transformation of cells in vitro [8]
confirming that this pathway is involved in oncogenic
transformation caused by Env.
On the other hand, in BEAS-2B cells, the MEK inhibi-
tors as well as the PI3K inhibitor were able to inhibit
cell migration (Figure 5B). In BEAS-2B, multiple path-
ways seem to function in an overlapping manner and
therefore a single pathway could not be attributed to a
particular physiological function. BEAS-2B-Env cells do
not have enhanced proliferation rate and therefore
further investigation for attribution of pathway specifi-
city to proliferation was conducted using A549-Env
cells.
Akt pathway is highly enhanced in A549-Env cells and
therefore is correlated with its very high proliferation
potential. When A549-Env cells were allowed to prolif-
erate in the presence of MEK inhibitors or PI3K inhibi-
tor, only the latter (LY294002) was able to inhibit
proliferation, confirming that the PI3K/Akt pathway is
required for their enhanced proliferation potential (Fig-
ure 5C). Our observations suggest that the Akt pathway
is involved in proliferation and the ERK pathway in
migration of A549 and its derivative cell lines.
The amino acids Y55 and Y227 are crucial for the
function of Sprouty2
Our observations implicate that Sprouty2 has the poten-
tial to alter the physiology of A549 and therefore further
investigations on the tumor suppressive functions of
Sprouty2 were conducted using A549. To ascertain the
role of Sprouty2 in inhibiting cell migration, tumor for-
mation and anchorage-independent growth, functional
mutants of Sprouty2 were created. Two key tyrosine
residues, Y55 and Y227 have been identified in human
Sprouty2 protein, mutations of which seem to affect its
interaction with the other signaling molecules as well as
i t sf u n c t i o na sa nE R Ki n h i b i t o r .Y 5 5r e s i d u ei st h e
major tyrosine crucial for the function of Sprouty2, in
the absence of which, Y227 can mediate some of its
functions [27,68,69]. We created two mutants of Spro-
uty2 - Y55F and Y227F by site-directed mutagenesis and
expressed them in A549 cells to create ‘A549-Y55FSpr’
and ‘A549-Y227FSpr’ stable cell lines respectively. The
mutants are envisaged to interrupt the functions of
endogenous Sprouty2.
Functional analysis revealed that while both A549-
Y55FSpr and A549-Y227FSpr cells were capable of
anchorage-independent colony formation, the former
was more potent causing an increase in colony size
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Figure 5 ERK and PI3K pathways regulate cell migration and
proliferation. A549 (A) or BEAS-2B (B) cells were allowed to
migrate across the 8 μm porous membrane in a Boyden chamber
either alone or in the presence of PI3K inhibitor LY294002 (20 μM)
or MEK inhibitors U0126 (20 μM) or PD98059 (20 μM) in response to
serum. After 15 h, the migrated cells were fixed, stained and
counted. (A) *P < 0.0001; (B) *P < 0.0003). (C) A549-Env cells were
allowed to proliferate either alone or in the presence of MEK
inhibitor U0126 (1 μM) or (5 μM) or PI3K inhibitor LY294002 (5 μM)
or (20 μM). Data shown represent proliferation at 72 h. (*P <
0.0001).
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Page 9 of 18Figure 6 Tyrosine mutants of Sprouty2 inhibit its tumor suppressive function. Stable transfectants of A549 over expressing either Y55F or
Y227F mutant of Sprouty2 designated A549-Y55FSpr and A549-Y227FSpr respectively were created and assayed for their functional properties.
(A) and (B) Colony formation assay: A549, A549-Y55FSpr and A549-Y227FSpr cells were cultured in soft agar to assess their anchorage-
independent colony formation ability. (A) The colonies were counted and photographed on day 12. (B) Graphical representation of the number
of colonies formed by each cell line. (C) Equal numbers (1 × 10
5 cells/well) of A549, A549-Y55FSpr and A549-Y227FSpr cells were allowed to
proliferate for four days. Schematic representation of their proliferation rate represented by live cell count every 24 h. (D) In vivo tumor
formation: A549, A549-Spr or A549-Y55FSpr or A549-Y227FSpr cells were injected into the subcutaneous tissue of SCID mice. Growth rate of
tumors formed by the respective cell lines in SCID mice is represented as increase in tumor volume monitored for up to 5 weeks. (E) Migration
assay: Cells were allowed to migrate across the 8 μm porous membrane in a Boyden chamber in response to serum. After 15 h, the migrated
cells were fixed, stained and counted. (*P = 0.0029). (F) Western blot analysis of the cell lysates of A549, A549-Spr, A549-Y55FSpr and A549-
Y227FSpr to check for the levels of phospho ERK p44/42 and total ERK p44/42.
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Page 10 of 18(Figure 6A) as well as colony number compared to A549
(Figure 6B). A549-Y227FSpr formed smaller and fewer
colonies than A549-Y55FSpr. The proliferation rate of
A549-Y55FSpr was higher than that of A549 while
A549-Y227FSpr was comparable to A549 (Figure 6C).
These observations corroborate the finding that Y55 is
the major tyrosine residue crucial for Sprouty2 function.
When these cells were injected into SCID mice subcu-
taneously to compare the tumor forming potential, it
was observed that the tumor growth rate of A549-
Y55FSpr was marginally greater than that of A549,
while A549-Y227FSpr had a tumor growth rate less than
A549, but greater than A549-Spr (Figure 6D).
The effect of the functional mutants of Sprouty2 on
cell migration was investigated. A549-Y55FSpr had
~1.5-fold increased migration potential than A549 while
the migration potential of A549-Y227FSpr was compar-
able to that of A549 (Figure 6E). These observations
confirm the inhibitory effect of the tyrosine mutants on
endogenous Sprouty2 function and the inhibitory role of
Sprouty2 in tumorigenesis, anchorage-independence and
migration. These data also confirm that Tyr55 plays a
more significant role in Sprouty2 function than Tyr227
and therefore is more effective in disrupting the func-
tion of endogenous Sprouty2.
An analysis of the alteration of signaling network in
these cell lines revealed that ERK phosphorylation was
not inhibited in both A549-Y55FSpr and A549-
Y227FSpr, whereas inhibition of ERK phosphorylation is
a characteristic feature of A549-Spr (Figure 6F). The
profile of other signaling molecules such as Akt, p38
MAPK, STAT3, and PTEN in A549 transfected with the
mutants was similar to that of A549 (data not shown).
Based on these observations we assume that the major
inhibitory effect of wild type Sprouty2 is due to its inhi-
bition of the ERK pathway.
Overexpression of Sprouty2 makes cells resistant to Env-
mediated transformation
To study the correlation between Sprouty2 and the viral
oncogene Env, A549-Spr and BEAS-2B-Spr cells overex-
pressing Sprouty2 were transfected with a plasmid carry-
ing Env gene to allow the formation of distinct foci, a
hall mark of Env-induced transformation. Fourteen days
after transformation with Env, A549 cells showed a
number of large distinct foci (A549 + Env) while very
few small foci were seen in A549-Spr (A549-Spr + Env)
(Figure 7). Similarly, BEAS-2B developed distinct foci
upon transformation with Env (BEAS-2B + Env) while
in BEAS-2B-Spr (BEAS-2B-Spr + Env), foci formation
was not observed (Figure 7). Env and Sprouty2 both
seem to affect transformation of target cells, with Env
promoting it and Sprouty2 antagonizing it. BEAS-2B-
Spr had decreased migration rate and decreased
phosphor- ERK levels compared to BEAS-2B (data not
shown), but otherwise, both the cell lines were compar-
able in terms of their functionality and the status of sig-
naling molecules. Interference of foci formation in
BEAS-2B-Spr and A549-Spr cells indicates that Sprouty2
inhibits Env-mediated transformation.
A549-Spr cells transfected with Env (A549-Spr-Env)
had similar rates of proliferation and migration like
A549-Spr and were unable to form colonies in soft agar
(data not shown). When injected into SCID mice, their
tumor forming potential was only marginally enhanced
than that of A549-Spr in terms of tumor size (Figure 8A
and 8B) and tumor weight (Figure 8C). Env was there-
fore unable to endow rapid proliferation and tumor for-
mation potential to A549-Spr cells. These results
indicate that overexpression of Sprouty2 in both A549
and BEAS-2B cells that are normally susceptible to Env-
mediated transformation, had made them resistant to
the same. This can be attributed to the overexpression
of the tumor suppressor Sprouty2 and subsequent
alterations in the physiological and signaling status of
the cells.
Oncogenesis results from changes in kinetics or abun-
dance of proteins in signal transduction networks with
the control dispersed over many components. While the
MAPK and PI3K pathways are crucial for Env to induce
transformation and proliferation, Sprouty2 also has
some connections to these pathways. The effect of Spro-
uty2 (wild type as well as Y55F or Y227F mutants) and
Env on the major signaling elements and their effect on
the functional outcomes of different cells are depicted in
Figure 9. Sprouty proteins are well documented to be
feedback negative regulators of the MAPK pathway
[20,21]. Sprouty2 is reported to bind to phosphatidylino-
sitol-4, 5-biphosphate, a substrate for PI3K by means of
its translocation domain [70]. Mouse Sprouty4 is
reported to have an inhibitory effect on Akt phosphory-
lation [71]. Therefore, resistance to Env by modulation
of PI3K pathway by Sprouty2 is a possibility and can
not be ruled out. We could not identify any direct inter-
action between Env and Sprouty2 proteins (data not
shown), as has been documented for many oncoprotein-
tumor suppressor protein pairs. Multiple oncoproteins
and tumor suppressor proteins have been found to act
through the same signaling pathway, to cause or prevent
cellular transformation [72]. Similarly, Env and Sprouty2
might affect the same signaling pathways in either a
synergistic or antagonistic manner. Parallel Ras/MAPK
and PI3K pathways with common connections [73,74]
are known to exist in many scenarios. We therefore pro-
pose dual regulation of the PI3K/Akt and ERK pathways
by both Env and Sprouty2, thereby constituting a func-
tional cross talk. We propose that Sprouty2 resists Env-
mediated transformation by modulating the signaling
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BEAS-2B + Env
A549
A549 + Env
BEAS-2B-Spr + Env
A549-Spr BEAS-2B-Spr
A549-Spr + Env
Figure 7 Sprouty2 overexpressing cells are resistant to Env-mediated transformation. A549, A549-Spr, BEAS-2B and BEAS-2B-Spr cells were
transfected with the plasmid carrying Env gene by standard calcium chloride method. Foci formation after 14 days was monitored and
photographed at 10× magnification.
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Page 12 of 18pathways, subsequently altering the biochemical status
of the cells to make them resistant to oncogenic
transformation.
Conclusions
Proliferation and invasion functions can be governed by
distinct signaling pathways in the cells and therefore can
be evoked independently in the target cells. Oncogenic
Env from JSRV and the tumor suppressor human
Sprouty2 participate in overlapping signal transduction
pathways and therefore are capable of influencing each
other, determining the susceptibility of target cells to
oncogenic transformation. Both play very relevant roles
in cancer induction, progression and invasion. Sprouty2
has a clear role in cell migration, invasion and tumor
formation, and its Y55 residue plays a crucial role in its
functionality. Sprouty2 shows distinct potential for being
exploited as an anti-cancer therapeutic agent for tumor
regression and inhibition of cancer invasion and
metastasis.
Methods
Cell culture
A549, lung adenocarcinoma cell line and its transfor-
mants were maintained in Dulbecco’s modified Eagle’s
medium with high glucose (4.5 g/L) supplemented with
10% bovine serum, 2 mM L-glutamine, 100 units/ml
penicillin and 100 units/ml streptomycin (Invitrogen,
CA, USA) in a 5% CO2 humidified incubator at 37°C.
Both stable and transient transfections were done by
standard calcium chloride method, unless otherwise
indicated. Cells were grown to 80% confluency in a 10-
cm dish and were transfected with the plasmids carrying
Sprouty or JSRV Env genes. In short, 28 μg of plasmid
DNA was mixed with 86.8 μl of 2 M CaCl2 solution and
t h ev o l u m ew a sa d j u s t e dt o6 0 0μl with sterile distilled
water. This solution was added dropwise with constant
stirring to equal volume of HEPES buffered saline (0.28
M NaCl, 0.05 M HEPES, 1.5 mM Na2HPO4,p H7 . 0 )
and the resultant suspension was added to the cells and
incubated overnight. Fresh medium was replaced in the
morning. A549 and BEAS-2B cells were stably trans-
formed with pCDNA 3.1(-)-Sprouty2 to create A549-Spr
and BEAS-2B-Spr cell lines that overexpressed Sprouty2.
A549 was transfected with Sprouty2 mutants to create
A549-Y55FSpr and A549-Y227FSpr cell lines. A549 and
BEAS-2B cells were transfected with pBS-Env and the
stable clones were selected from the foci of transformed
cells, and developed into A549-Env and BEAS-2B-Env
cell lines. Env-transformed cells were selected based on
their foci forming ability and serum independence as
d e s c r i b e dp r e v i o u s l y[ 9 , 7 5 ] .W i l dt y p eo rm u t a n tS p r o -
uty-transformed cells were selected with 600 μg/ml of
G418 (Sigma-Aldrich, St Louis, MO, USA). BEAS-2B,
lung epithelial cell line was maintained in LHC-9 med-
ium (Invitrogen) supplemented with 100 units/ml peni-
cillin and 100 units/ml streptomycin and maintained as
above.
Plasmids and primers
Full length of JSRV Envelope gene [Genbank:AF105220]
(nucleotides 5348 to 7195) cloned in pBluescript (KS
-)
vector under CMV promoter was gifted by Hung Fan,
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Figure 8 A549-Spr-Env cells lack enhanced tumor forming
potential in vivo. (A) Pictures of in vivo tumors formed by A549-Spr
and A549-Spr-Env cells injected into the subcutaneous tissue of
SCID mice and excised on day 34. (B) Growth rates of the tumors
formed by the respective cell lines in SCID mice represented as
tumor volume monitored for up to 5 weeks. (C) Average weight of
tumors resected from SCID mice 34 days after injection. (*P =
0.0369).
Chitra et al. Retrovirology 2010, 7:62
http://www.retrovirology.com/content/7/1/62
Page 13 of 18University of California, Irvine, USA. Full length cDNA
of human Sprouty2 gene was cloned by RT-PCR from
A549 cell line using the following primers, forward:
GGGAATTCCCAAGACCTGATGGAGGCCAG and
reverse: CAGGGATCCCTATGTTGGTTTTTCAAAG
TTCCTAG as described previously [33] into the expres-
sion vector pCDNA3.1(-) using EcoR1 and BamH1
restriction enzymes. The PCR conditions were: 45°C for
30 min, 94°C for 5 min; followed by 35 cycles of 94°C
for 45 sec, 59°C for 45 sec and 72°C for 75 sec; followed
by 72°C for 7 min. The dominant negative mutants of
Sprouty2, Y55F and Y227F were created by site-directed
mutagenesis by PCR using Pfu DNA polymerase and the
following primers. Y55F forward: CCGAAACACCAAT-
GAGTTCACAGAGG, Y55F reverse: CCTCTGTGAA
CTCATTGGTGTTTCGG, Y227F forward: GGTCTC
TTCTTT CACTGTTCTAATG and Y227F reverse:
CATTAGAACAGTGAAAGAAGAGACC. PCR condi-
tions for creation of Y55F mutant were: 94°C for 5 min;
followed by 30 cycles of 94°C for 45 sec, 55°C for 45 sec
and 72°C for 13 min; followed by 72°C for 30 min; and
for Y227F mutant, 94°C for 5 min; followed by 30 cycles
of 94°C for 45 sec, 52°C for 45 sec and 72°C for 13 min;
followed by 72°C for 30 min. After the PCR reaction,
Dpn1 restriction enzyme was used to digest the tem-
plate DNA. All the constructs were confirmed by
restriction enzyme digestion and sequence analysis. All
the enzymes were purchased from New England Biolabs
(Ipswich, MA, USA).
RT-PCR
RNA samples were isolated from A549 cells transiently
transfected with the empty vector (pBS) or Env gene
cloned in pBS (pBS-Env). On day 3 and 6, the cell lines
were treated with TRIZOL reagent (Invitrogen) and
total RNA was isolated following the manufacturer′s
instructions. Human Sprouty2 mRNA and b-actin
mRNA were detected by reverse transcription-polymer-
ase chain reaction (RT-PCR) analysis using one-step
RT-PCR Premix reagent (iNtRON Biotechnology, Korea)
and the following primers: Sprouty2 forward: 5′-CCAA-
GACCTGATGGAGGCCAG-3′, Sprouty2 reverse: 5′-
TGTTGGTTTTTCAAAGTTCCTAGG-3′, b-actin for-
ward: 5′-TGCGTGACATTAAGG AGAAG-3′ and b-
actin reverse: 5′-CTGCATCCTGTCGGCAATG-3′.T h e
PCR conditions were 45°C for 30 min, 94°C for 5 min;
followed by 35 cycles of 94°C for 45 sec, 59°C (for Spro-
uty) or 56°C (for b-actin) for 45 sec and 72°C for 75 sec,
followed by incubation at 72°C for 7 min.
Quantitative RT-PCR
Total RNA (2 μg) isolated from the stable cell lines
A549, A549-Spr and A549-Env was converted to cDNA
using Superscript II reverse transcriptase enzyme and
PI3K
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Figure 9 Schematic diagram representing the alteration of signaling network by Sprouty2 and Env. Schematic diagram represents the
interaction of signaling molecules and their proposed physiological outcomes. The levels of phospho Akt, phospho ERK, Sprouty2 and phospho
STAT3 in the cell lines A549, A549-Spr, A549-Y55FSpr/A549-Y227FSpr and A549-Env are represented. ↑ indicates upregulation, ↓ indicates
downregulation, + indicates presence without any increase or decrease. The functional outcomes in terms of proliferation, tumor formation,
migration and anchorage-independent colony formation in the above mentioned cell lines are also represented.
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turer’s instructions. The expression levels of hSprouty2
relative to the house keeping gene, glucose 6-phosphate
dehydrogenase (G6PD) was assessed in the stable cell
lines by quantitative PCR analysis of the cDNA using
ABI PRISM 7900 sequence detection system using
SYBR Green with the following primers: Sprouty for-
ward: TGGC AAGTGCAAATGTAAGG and Sprouty
reverse: CTTGTCGCAGATCCAGTCC, G6PD forward:
GCAAACAGAGTGAGCCCTTC and G6PD reverse:
GGCCAGCCACATAG GAGTT. Data were expressed
using the comparative Ct method [76] as fold increase
in hSprouty2 expression compared to the internal con-
trol, G6PD.
Western Blot Analyses
Western blot was carried out as described [16] using the
SuperSignal West Pico chemiluminescent substrate
(Pierce, Rockford, IL, USA) with the following antibo-
dies against phospho Thr180/Tyr182 p38 MAPK, p38
MAPK, phospho Thr202/Tyr204 p44/42 ERK, p44/42
ERK, phospho Ser473 Akt, Akt, phospho Tyr705
STAT3, STAT3, phospho Ser380 PTEN, PTEN (Cell
Signaling Technology, MA, USA), Sprouty (Upstate Bio-
technology, Billerica, MA, USA), TWIST (Santa Cruz
Biotechnology, CA, USA), TIMP1, TIMP2, b-actin
(Abcam, Cambridge, MA, USA) followed by the appro-
priate secondary antibodies conjugated to HRP (Thermo
Fisher Scientific, MA, USA). Cytoplasmic and nuclear
extracts were prepared using NE-PER kit (Pierce) fol-
lowing manufacturer’s instructions. For detection of
secreted TIMPs, conditioned media (without FBS)
obtained from the different cell lines were concentrated
20-fold using Amicon Ultra centrifugal filter devices (10
Kea) (Millipore, MA, USA) and sample corresponding
to 1 ml medium was loaded per well. The blots were
quantified using Image J software (NIH, USA).
MMP Zymogram
20 μl of conditioned media (without FCS) obtained from
different cell lines after 24 h incubation were assayed for
gelatinase activity using 10% SDS-PAGE gels containing
gelatin (0.1% w/v; Sigma-Aldrich) [77,78]. Gels were
stained with 0.2% Coomassie brilliant blue R-250 (Bio-
Rad Laboratories, CA, USA) and destained in a solution
containing 30% methanol and 10% acetic acid. Gelati-
n a s ea c t i v i t yw a sv i s u a l i z e da sc l e a r e dr e g i o n si nt h e
blue gels.
Proliferation assay
Cells were serum starved over night and seeded (1 × 10
5
cells per well) in a 24- well culture plate in triplicates in
DMEM medium with 10% FBS and incubated at 37°C in
a5 %C O 2 humidified incubator. After 24, 48, 72 and
96 hours, the live cell number was determined by trypan
blue exclusion using a haemocytometer. When using
pharmacological inhibitors, the cells were pretreated
with MEK inhibitors U0126 (5 or 20 μM) or PI3K inhi-
bitor LY294002 (5 or 20 μM) (Sigma-Aldrich) for
30 min and allowed to migrate in the presence of the
inhibitors with periodical addition every 36 h.
Migration assay
In vitro migration assays were performed using Corning
Costar transwell supports (Corning, NY, USA) contain-
ing a gelatin-coated polycarbonate membrane filter (6.5
mm diameter, 8 μM pore size) in a 24-well assay system.
DMEM with 10% FBS was placed in the lower chamber
and in the upper chamber 50,000 cells suspended in
DMEM with 1% FBS were placed. The setup was kept
in 5% CO2 humidified incubator. After 15 h, the
migrated cells in the lower surface were fixed with 4%
formaldehyde, stained with crystal violet, viewed under a
microscope, photographed and counted.
When using pharmacological inhibitors, the cells were
pretreated with the MEK inhibitors PD98059 (20 μM)
or U0126 (20 μM) or the PI3K inhibitor LY294002
(20 μM) for 30 min and then allowed to migrate in the
presence of the inhibitors.
siRNA to Sprouty2
Cells were grown in a 6-well plate to 80% confluency
and transfected with 200 pico moles of human Spro-
uty2-specific siRNA or control siRNA (Santa Cruz Bio-
technology). To 50 ĀL of culture medium pre-mixed
with 1 ĀL of TurboFect transfection reagent (Fermentas,
Maryland, USA), 200 pmoles of siRNA was added and
the mixture was added per well of the 6-well plate. Cells
were incubated at 37°C for 24 h and then trypsinized,
counted and subjected to cell migration assay or cell
lysates were prepared for Western blotting as described
above.
Colony formation assay
In 60 mm culture dishes, 0.5% agarose in DMEM with
10% FBS was added as the base agar followed by a top
layer containing 5000 cells in DMEM with 0.35% low
melting agarose and 10% FBS. DMEM with 10% FBS
was overlaid on the top agar. Plates were incubated in
5% CO2 humidified incubator for 14 days with periodi-
cal medium changes. The colonies were stained with
crystal violet and counted. Triplicates were maintained
for each group.
Tumor cells xenografts in SCID mice
Subcutaneous tumors were generated by injecting 1 ×
10
6 cells in 0.1 ml saline subcutaneously in the thighs of
7 weeks old female NOD.CB17-Prkdc
scid (SCID) mice
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ter (Taipei, Taiwan ROC). Five to seven mice were used
for each treatment and they were monitored twice
weekly for tumor development, and tumor diameter was
measured using calipers. Tumor volume was determined
using the formula, volume = 0.52 × (width) × (length).
The tumors were resected after 34 days, weighed and
processed for histological analysis. All the experimental
procedures were in accordance with the institutional
guidelines of Animal Care and Use Committee of the
Animal Facility in National Health Research Institutes.
Histological analysis
Excised tumors were fixed in 10% buffered neutral for-
malin solution (Sigma-Aldrich) overnight, dehydrated,
embedded in paraffin (Thermo Fisher Scientific), sec-
tioned at 4 μm thickness and stained with 1% hematoxy-
lin and eosin solution (Sigma-Aldrich). Bright field
microscopy pictures were taken at 400× magnifications.
Statistics
All the experiments were repeated independently 2-5
times.
Data are presented as mean ± SE. Differences between
the groups were assessed by paired Student’s t test using
Graphpad software.
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